Literature DB >> 29454490

Subchronic exposure to acrylamide leads to pancreatic islet remodeling determined by alpha cell expansion and beta cell mass reduction in adult rats.

Milena Stošić1, Milica Matavulj2, Jelena Marković3.   

Abstract

Acrylamide (AA) is a toxic substance, used to synthesize polymers for industrial and laboratory processes. Also, AA is a food contaminant formed during the high temperature preparation of carbohydrate-rich food. The main subject of this study was to examine effects of subchronic AA treatment on the islets of Langerhans of adult rats. Adult male Wistar rats were orally treated with 25 or 50 mg/kg bw of AA for 3 weeks. Qualitative and quantitative immunohistochemical evaluation of glucagon and insulin expression and stereological analyses of pancreatic alpha and beta cells were performed. Serum insulin and glucose levels were measured. Analysis of glucagon-immunostained sections revealed a dose-dependent increase of intensity of glucagon immunopositive signal, alpha cell surface and numerical densities, volume density of alpha cell nuclei and nucleocytoplasmic ratio in AA-treated groups compared to the control. In insulin-immunolabeled pancreatic sections in AA-treated animals was observed decrease of intensity of insulin immunopositive signal, beta cell surface, numerical and volume densities and volume density of beta cell cytoplasm. Serum insulin and glucose concentrations remained unchanged after both AA treatments. The number of islets of Langerhans was not affected by AA treatment. Our results suggest that AA subchronic treatment of adult rats leads to remodeling of islet of Langerhans characterized by alpha cell expansion and beta cell mass reduction.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acrylamide; Adult rats; Alpha cell; Beta cell; Histology; Islets of Langerhans

Mesh:

Substances:

Year:  2018        PMID: 29454490     DOI: 10.1016/j.acthis.2018.02.002

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  4 in total

1.  Effect of Acrylamide Treatment on Cyp2e1 Expression and Redox Status in Rat Hepatocytes.

Authors:  Jelena Marković Filipović; Marko Miler; Danijela Kojić; Jelena Karan; Ivana Ivelja; Jovana Čukuranović Kokoris; Milica Matavulj
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

Review 2.  Acrylamide and Potential Risk of Diabetes Mellitus: Effects on Human Population, Glucose Metabolism and Beta-Cell Toxicity.

Authors:  Jelena Marković Filipović; Jelena Karan; Ivana Ivelja; Milica Matavulj; Milena Stošić
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

3.  Oral Administration of Acrylamide Worsens the Inflammatory Responses in the Airways of Asthmatic Mice Through Agitation of Oxidative Stress in the Lungs.

Authors:  Bahador Hajimohammadi; Seyyede Masoume Athari; Mohammad Abdollahi; Ghasem Vahedi; Seyyed Shamsadin Athari
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

4.  The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia.

Authors:  Huanyu Wu; Xinyi Sun; Hongyan Jiang; Cong Hu; Jiaxu Xu; Changhao Sun; Wei Wei; Tianshu Han; Wenbo Jiang
Journal:  Front Cardiovasc Med       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.